• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿根廷胃食管反流的患病率、临床谱及非典型症状:一项基于全国人口的研究。

Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study.

作者信息

Chiocca J C, Olmos J A, Salis G B, Soifer L O, Higa R, Marcolongo M

机构信息

Department of Gastroenterology, Hospital Nacional Prof. Dr Alejandro Posadas, El Palomar, Buenos Aires, Argentina.

出版信息

Aliment Pharmacol Ther. 2005 Aug 15;22(4):331-42. doi: 10.1111/j.1365-2036.2005.02565.x.

DOI:10.1111/j.1365-2036.2005.02565.x
PMID:16098000
Abstract

BACKGROUND

Population-based data on gastro-oesophageal reflux in Latin America are lacking.

AIM

To assess gastro-oesophageal reflux symptom prevalence, clinical spectrum and association with the atypical symptoms in our country.

METHODS

Gastro-oesophageal reflux self-report questionnaires validated at Mayo Clinic, USA, were submitted to a sample of 1000 residents (aged 18-80 years) from 17 representative geographical areas of Argentina. The samples were selected and stratified according to age, gender, geographical areas and size of town of residence provided by the Argentine Bureau of Statistics and Census.

RESULTS

The overall prevalence of any typical gastro-oesophageal reflux symptom experienced in the previous year was 61.2% (95% CI, 57.9-64.6), the prevalence of frequent gastro-oesophageal reflux symptoms was 23.0% (95% CI, 20.1-25.9) and the prevalence of gastro-oesophageal reflux disease was 11.9% (95% CI, 9.6-14.1). Frequent gastro-oesophageal reflux symptoms were associated with dysphagia (OR 2.12, 95% CI, 1.27-3.54, P < 0.01), globus (OR 2.22, 95% CI, 1.35-3.66, P < 0.01) and non-cardiac chest pain (OR 1.55, 95% CI, 1.04-2.31, P < 0.05).

CONCLUSIONS

In Argentina, typical symptoms of gastro-oesophageal reflux are highly prevalent at the national level, and frequent gastro-oesophageal reflux symptoms are significantly associated with dysphagia, globus and non-cardiac chest pain.

摘要

背景

拉丁美洲缺乏基于人群的胃食管反流数据。

目的

评估我国胃食管反流症状的患病率、临床谱及其与非典型症状的关联。

方法

将在美国梅奥诊所验证过的胃食管反流自我报告问卷提交给来自阿根廷17个代表性地理区域的1000名居民(年龄在18 - 80岁之间)。样本根据年龄、性别、地理区域以及阿根廷统计局和人口普查局提供的居住城镇规模进行选择和分层。

结果

上一年出现任何典型胃食管反流症状的总体患病率为61.2%(95%可信区间,57.9 - 64.6),频繁胃食管反流症状的患病率为23.0%(95%可信区间,20.1 - 25.9),胃食管反流病的患病率为11.9%(95%可信区间,9.6 - 14.1)。频繁胃食管反流症状与吞咽困难(比值比2.12,95%可信区间,1.27 - 3.54,P < 0.01)、咽部异物感(比值比2.22,95%可信区间,1.35 - 3.66,P < 0.01)和非心源性胸痛(比值比1.55,95%可信区间,1.04 - 2.31,P < 0.05)相关。

结论

在阿根廷,胃食管反流的典型症状在全国范围内高度流行,且频繁胃食管反流症状与吞咽困难、咽部异物感和非心源性胸痛显著相关。

相似文献

1
Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study.阿根廷胃食管反流的患病率、临床谱及非典型症状:一项基于全国人口的研究。
Aliment Pharmacol Ther. 2005 Aug 15;22(4):331-42. doi: 10.1111/j.1365-2036.2005.02565.x.
2
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea.胃食管反流的患病率及临床谱:韩国牙山市一项基于人群的研究
Am J Gastroenterol. 2005 Apr;100(4):747-53. doi: 10.1111/j.1572-0241.2005.41245.x.
3
Risk factors for non-cardiac chest pain in the community.社区中非心源性胸痛的危险因素。
Aliment Pharmacol Ther. 2005 Nov 15;22(10):1023-31. doi: 10.1111/j.1365-2036.2005.02666.x.
4
Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study.中国人群反流症状的发作与消失:一项为期1年的随访研究。
Aliment Pharmacol Ther. 2004 Oct 1;20(7):803-12. doi: 10.1111/j.1365-2036.2004.02198.x.
5
Risk factors for gastro-oesophageal reflux disease symptoms: a community study.胃食管反流病症状的危险因素:一项社区研究。
Aliment Pharmacol Ther. 2005 Apr 1;21(7):821-7. doi: 10.1111/j.1365-2036.2005.02426.x.
6
Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain.西班牙非典型症状的患病率及其与胃食管反流典型症状的关联。
Eur J Gastroenterol Hepatol. 2006 Sep;18(9):969-75. doi: 10.1097/01.meg.0000230081.53298.03.
7
Nutcracker oesophagus: association with chest pain and dysphagia controlling for gastro-oesophageal reflux.胡桃夹食管:与胸痛及吞咽困难的关联——对胃食管反流进行控制的研究
Dig Liver Dis. 2008 Sep;40(9):717-22. doi: 10.1016/j.dld.2008.02.018. Epub 2008 Apr 3.
8
The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.大剂量兰索拉唑经验性试验对非心源性胸痛患者症状反应的影响——一项随机、双盲、安慰剂对照、交叉试验。
Aliment Pharmacol Ther. 2004 May 15;19(10):1123-30. doi: 10.1111/j.1365-2036.2004.01941.x.
9
Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor.胃食管反流病的流行病学研究:配偶反流作为一个危险因素
Aliment Pharmacol Ther. 2008 Jul;28(1):144-53. doi: 10.1111/j.1365-2036.2008.03708.x. Epub 2008 Apr 11.
10
Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population.胃食管反流病与肠易激综合征:伊朗人群中的显著关联。
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):719-25. doi: 10.1097/MEG.0b013e3282f88a42.

引用本文的文献

1
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility.食管和口咽吞咽困难:欧洲胃肠病学联合会和欧洲神经胃肠病学与动力学会的临床建议
United European Gastroenterol J. 2025 Jul;13(6):855-901. doi: 10.1002/ueg2.70062. Epub 2025 Jun 21.
2
Advancements and Challenges in Non-Invasive Sensor Technologies for Swallowing Assessment: A Review.吞咽评估无创传感器技术的进展与挑战:综述
Bioengineering (Basel). 2024 Apr 27;11(5):430. doi: 10.3390/bioengineering11050430.
3
Sex difference in the associations among risk factors with gastroesophageal reflux disease in a large Taiwanese population study.
在一项大型台湾人群研究中,危险因素与胃食管反流病之间的关联存在性别差异。
BMC Gastroenterol. 2024 May 15;24(1):165. doi: 10.1186/s12876-024-03254-3.
4
Why so Many Patients With Dysphagia Have Normal Esophageal Function Testing.为什么这么多吞咽困难患者的食管功能测试结果正常。
Gastro Hep Adv. 2024;3(1):109-121. doi: 10.1016/j.gastha.2023.08.021. Epub 2023 Oct 5.
5
Latin American consensus on diagnosis of gastroesophageal reflux disease.拉丁美洲胃食管反流病诊断共识。
Neurogastroenterol Motil. 2024 Mar;36(3):e14735. doi: 10.1111/nmo.14735. Epub 2024 Jan 15.
6
Non-cardiac Chest Pain in Japan: Prevalence, Impact, and Consultation Behavior - A Population-based Study.日本的非心源性胸痛:患病率、影响及就诊行为——一项基于人群的研究
J Neurogastroenterol Motil. 2023 Oct 30;29(4):446-454. doi: 10.5056/jnm22184.
7
A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State.10毫克非布司他的比较药代动力学研究:证明与参比制剂生物等效并评估稳态
Pharmaceuticals (Basel). 2023 Aug 11;16(8):1141. doi: 10.3390/ph16081141.
8
Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation.20毫克的微粉化非布瑞嗪与参比制剂相比,具有最佳的生物利用度和生物等效性。
Transl Clin Pharmacol. 2023 Mar;31(1):40-48. doi: 10.12793/tcp.2023.31.e3. Epub 2023 Mar 22.
9
Clinical Implications of the Gastroesophageal Reflux Disease Questionnaire and Reflux Symptom Index in Patients With Suspected Laryngopharyngeal Reflux Symptoms.胃食管反流病问卷和反流症状指数在疑似喉咽反流症状患者中的临床意义
J Neurogastroenterol Motil. 2022 Oct 30;28(4):599-607. doi: 10.5056/jnm21235.
10
Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease.用于诊断胃食管反流病的夜间平均基础阻抗和反流后吞咽诱导蠕动波指数的临床应用。
Esophagus. 2022 Oct;19(4):525-534. doi: 10.1007/s10388-022-00933-6. Epub 2022 Jun 29.